Non-Dilutive Funding Sources for Healthcare Startups

Mayur Toshniwal
Last updated on January 15, 2026
Non-Dilutive Funding Sources for Healthcare Startups

Non-dilutive funding is becoming a serious lifeline for HealthTech founders who want capital without giving up ownership. Instead of trading equity for runway, you use grants, contracts, partnerships, and revenue-based support to keep control while still moving fast.

The scale of capital flowing into the sector shows what’s at stake. In 2024, healthcare startups raised $23 billion across 1,387 venture rounds, underscoring both the opportunity and the competition for funding. Understanding that landscape helps founders set realistic expectations, and see where non-dilutive funding fits into a smarter, more founder-friendly capital strategy.

This guide explains where non-dilutive funding fits into that landscape and shows you how to use it as part of a smarter, more founder-friendly capital strategy.

What Is Non-Dilutive Funding?

Non-dilutive funding is money you use to grow your startup without giving up equity or ownership. No new shares issued, no extra board seats, no loss of control. For healthcare and HealthTech founders, it’s often the difference between building on your terms and building on investor terms.

Instead of selling part of your company, you tap into:

  • grants
  • awards and competitions
  • research or innovation programmes
  • revenue-based support
  • certain types of crowdfunding or paid pilots

For example, a startup might secure a grant to run a clinical trial or real-world pilot before approaching investors. That way, when you do talk to VCs or angels, you’re walking in with evidence, not just a slide deck, and likely negotiating from a stronger position.

Case Studies

Startups like yours already closed their rounds with us.

Founders across every stage and industry. Here's what it took.

  • Raised $7.6M for Swiipr Technologies
  • Raised $0.5M for Ap Tack
  • Raised €0.5M for Ivent Pro
Read their stories

Why Non-Dilutive Funding Matters in Healthcare

Non-dilutive funding is often not just helpful in healthcare—it’s essential. Many founders discover quickly that traditional venture capital is harder to access than it looks, especially at the earliest stages when risk is highest and evidence is thinnest.

Recent data shows how tight things have become: in Q4 2024, median healthcare funding rounds were 30% smaller at seed and 31% smaller at Series A compared to the previous year. Smaller cheques and higher expectations mean fewer founders can rely on VC alone.

That’s why alternative, non-dilutive sources, grants, fellowships, pilots, contracts, and innovation programmes, are increasingly critical. They give healthcare entrepreneurs a way to fund clinical validation, compliance, and product development without surrendering equity at the most expensive point in their company’s life.

Types of Non-Dilutive Funding for Healthcare Startups

There are several types of non-dilutive funding available for healthcare startups

1. Government Grants and Subsidies

Grants are the classic non-dilutive option. Governments worldwide invest in healthcare innovation because better health outcomes benefit everyone. The best part? You don’t have to pay the money back, and you keep your equity.

United States

  • Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs: These federal grants support research-focused startups. Phase I grants can be up to $150,000 for feasibility studies; Phase II grants can reach $1 million for product development. The National Institutes of Health (NIH) is a major player. For more information, see our NIH SBIR & STTR Grants: A Quick Guide.
  • The Biomedical Advanced Research and Development Authority (BARDA) funds later-stage health security innovations, especially those addressing national threats like pandemics.
  • The Congressionally Directed Medical Research Program (CDMRP) supports a wide range of biomedical research, including clinical trials.

India

  • Biotechnology Ignition Grant (BIG): Managed by BIRAC, this grant offers up to ₹50 lakh for early-stage healthcare and biotech startups. It’s designed for proof-of-concept and prototype development.
  • National Health Mission (NHM): Provides grants for healthcare infrastructure, especially in rural areas. If your startup addresses maternal and child health or telemedicine, this is worth a look.

Europe

  • EIC Accelerator: The European Innovation Council offers significant non-dilutive support for deep tech, including health innovations.

Public funding can be a game-changer for cash-strapped HealthTech ventures, Government Grants & Subsidies for HealthTech walks through the top grant programs, eligibility hurdles, and application best practices so you can tap into non-dilutive support.

How to Succeed with Grants

  • Know the criteria. Each grant has strict eligibility and reporting requirements.
  • Start early. Applications take time, sometimes months.
  • Lean on experts. Many founders find it helpful to work with consultants or organizations that specialize in grant writing.

Collaboration Models for Federal Research Funding

Model Resource Access IP Protection
Direct Grant Funding only, limited lab access IP owned by recipient
University Partnership Shared facilities and expertise Joint IP agreements required
CRADA Agreement Federal lab resources and data Custom IP terms, enhanced protection

2. Revenue-Based Financing

Revenue-based financing (RBF) is a funding model where investors provide capital in exchange for a percentage of future revenue. You get upfront cash and, in return, agree to pay back a percentage of your monthly revenue. Repayment continues until you have paid back the original investment plus a fee.

Who’s it for?
Startups with predictable or growing revenue, like SaaS health platforms or service providers.

Pros:

  • Flexible repayments.
  • No dilution.

Cons:

  • Not available for pre-revenue startups.
  • Total repayment can be higher than traditional loans.

3. Crowdfunding

Crowdfunding is a non-dilutive funding option. Platforms like Kickstarter and Indiegogo let you raise funds directly from the public. In healthcare, this works best for products that resonate with consumers, think wearables, health apps, or wellness devices.

Types:

  • Reward-based: Backers get early access or perks.
  • Donation-based: Supporters contribute with no expectation of return.

Tips:

  • Tell a compelling story.
  • Offer meaningful rewards.
  • Build a community around your mission.

Securing non-dilutive funding often requires detailed planning and strategic alignment. To ensure your application startup stands out you should go for a step-by-step breakdown of how to position your healthcare startup effectively to attract funding, whether non-dilutive or traditional.

Competitions, Awards, and Innovation Prizes

Pitch competitions and innovation challenges can offer non-dilutive cash, mentorship, and exposure. These have become more sophisticated, less like demo-day theater, more like genuine funding sources.

Examples:

  • American-Made Solar Prize (for energy, but similar health-focused prizes exist).
  • Digital health startup competitions by organizations like MATTER, Cedars-Sinai, and others.

What to Expect:

  • Intense application and pitch process.
  • Valuable feedback, even if you don’t win.
  • Networking with investors and potential partners.

Accelerator and Incubator Programs

Some accelerators and incubators offer non-dilutive grants or stipends, along with mentorship, office space, and resources. However, many do take equity, so read the fine print.

Notable Non-Dilutive Examples:

  • Cedars-Sinai Accelerator: Offers $100,000 in funding, mentorship, and access to clinical expertise.
  • Global Health Accelerator: Focuses on early to mid-stage startups in health, biotech, and nanotech, providing entrepreneurship training and pilot development phases.

Recent accelerator cohorts have seen measurable impact. In 2024, 1,387 funding rounds were completed by healthcare startups, with many early-stage deals stemming directly from program participation. Such involvement can open the door to substantial resources beyond grant money.

Beyond direct capital, joining the right acceleration ecosystem fast-tracks growth, Accelerator & Incubator Programs Offering Seed Funding highlights HealthTech-focused programs, their typical investment sizes, selection criteria, and insider tips for standing out.

Non-Profit and Foundation Grants

Foundations like the Bill & Melinda Gates Foundation, the Robert Wood Johnson Foundation, and others regularly fund healthcare innovation, especially projects with global health impact.

What They Look For:

  • Clear social or health impact.
  • Strong evidence base.
  • Scalable solutions.

Tax Credits and Incentives

Many governments offer tax credits for R&D, hiring, or investment in innovation. While not direct cash, these incentives can free up resources for growth.

Examples:

  • R&D tax credits in the US, UK, Canada, Australia, and more.
  • Startup India incentives for Indian founders.

Venture Debt

Venture debt is a loan designed for startups that have already raised equity funding. It doesn’t dilute ownership, but it does require repayment with interest. It’s a good fit for companies with solid revenue or those looking to extend their runway between equity rounds.

Pros:

  • No equity loss.
  • Can be used to fund growth or bridge to next round.

Cons:

  • Requires strong financials.
  • Repayment is mandatory, regardless of business performance.

Strategic Considerations

While non-dilutive funding offers numerous advantages, it's essential to approach it strategically:

  • Understand Eligibility Criteria: Each funding source has specific requirements. Ensure your startup aligns with their objectives.
  • Prepare Thorough Applications: Non-dilutive funding is competitive. A well-prepared application increases your chances of success.
  • Diversify Funding Sources: Relying solely on one funding type can be risky. A mix of non-dilutive and dilutive funding can provide stability.

Engage Program Managers Early for Funding Success

Building on these strategic principles, founders should engage program managers at funding agencies early in their process. This outreach helps clarify eligibility, align proposals with agency priorities, and uncover upcoming opportunities. Early conversations can reveal specific expectations or focus areas not found in public guidelines. By fostering these relationships, startups increase their chances of crafting competitive applications and securing support.

If you do not qualify for non-dilutive or dilutive options, consider bootstrapping or forming partnerships for pilot work.

How Startups Use Non-Dilutive Funding

Let’s shuffle through a few real-world scenarios of how startups leverage non-dilutive funding.

The image highlights how different startups leveraged grants, accelerators, crowdfunding, and revenue-based financing at various stages. Each funding path is associated with early, scaling, or late startup stages.
  • A digital health startup in Los Angeles joined the Cedars-Sinai Accelerator, received $100,000, and leveraged mentorship to refine their product before seeking VC funding.
  • An Indian biotech founder secured a Biotechnology Ignition Grant (BIG) to build a prototype, then used that traction to attract private investment.
  • A US-based medtech team landed an NIH SBIR Phase I grant, developed proof-of-concept data, and later raised a Series A at a higher valuation because they’d de-risked their technology.
  • A wellness app founder ran a successful Kickstarter campaign, building a community of early adopters while raising $75,000 for product launch.
  • A SaaS health platform used revenue-based financing to fund a marketing push, repaying the advance as monthly revenue grew.

Notably, Abridge, a digital health leader in AI-driven clinical documentation, highlights the scale possible. In February 2024, Abridge secured $150 million in Series C funding just four months after finishing a $30 million Series B round. This represented one of the largest AI-focused healthcare deals of the year, showcasing how timely funding can accelerate growth and market leadership.

What Do Funders Want to See?

Every non-dilutive source has its own criteria, but some things are universal.

  • Clear Problem and Solution: Be specific about the health challenge you’re tackling.
  • Evidence and Traction: Show data, pilot results, or early user feedback.
  • Scalability: Funders want to see that your solution can grow and make a real impact.
  • Team: Highlight your expertise and commitment.
  • Sustainability: Explain how you’ll keep going after the grant or award ends.

Align Applications with Funder Mission and Priorities

This approach requires founders to tailor their applications to each funder’s mission and current healthcare priorities. Agencies increasingly focus on areas like AI, health disparities, and digital ethics. By aligning proposals with these evolving interests, startups demonstrate relevance and increase their chances of securing support. Understanding these priorities is essential for crafting compelling, competitive applications.

Conclusion

Non-dilutive funding isn’t a silver bullet, but it’s a powerful tool in your arsenal. The smartest founders use a mix—grants to get started, competitions for exposure, accelerators for mentorship, and maybe equity when the time is right. The key is to stay flexible, keep learning, and never let a “no” slow you down.

If you’re not sure where to start, pick one source and go deep. Apply for that grant. Enter that competition. Talk to an accelerator director. Every step builds momentum.

The journey to building a healthcare startup is tough, but with the right funding mix, you’ll keep more of your company and your vision intact. Strengthen your proposal through our healthcare fundraising assistance services and connect with our team today.

Key Takeaways

  • Non-dilutive funding lets healthcare startups grow without giving up equity or control.
  • Government grants, competitions, and foundation awards are major sources for early-stage capital.
  • Revenue-based financing and venture debt suit startups with existing revenue streams.
  • Crowdfunding and non-profit grants can help validate ideas and build early traction.
  • Success depends on clear problem-solving, strong evidence, and a committed team.
  • Combining non-dilutive and dilutive funding can maximize resources and valuation.
Fundraising Assistance

Get your round closed. Not just pitched.

A structured fundraising process matched to your stage and investor fit.

  • Fundraising narrative and structure that holds up
  • Support from strategy through investor conversations
  • Built around your stage, model, and timeline
Get fundraising support

Frequently asked Questions

What are the main types of non-dilutive funding for healthcare startups?

Healthcare startups can access non-dilutive funding through grants, awards, revenue-based financing, crowdfunding, and tax credits. Each type supports growth without equity loss.

How do government grants benefit early-stage healthcare startups?

Are accelerator programs always non-dilutive for healthcare startups?

Can healthcare startups combine non-dilutive and dilutive funding?

Are healthcare startup grants only for research?

Is non-dilutive funding slower than venture capital for healthcare startups?

How can pre-revenue healthcare startups access non-dilutive funding?